$-0.11
(Market cap
$1 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.6 %
-
ROCE
-- %
-
Industry P/E
46.09
-
EV/EBITDA
44.5
-
Debt to Equity
0.1
-
Book Value
$--
-
EPS
$-11.7
-
Face value
--
-
Shares outstanding
711,136
10 Years Aggregate
CFO
$-55.46 Mln
EBITDA
$-63.68 Mln
Net Profit
$-212.05 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Aethlon Medical (AEMD)
| -86.9 | -45.4 | -82.7 | -97.3 | -88.2 | -83.5 | -70.1 |
|
BSE Sensex*
| -10.5 | -3.5 | 2.0 | -6.1 | 4.6 | 5.4 | 10.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Aethlon Medical (AEMD)
| -96.0 | -60.4 | -20.5 | -84.9 | -24.7 | 156.5 | -96.1 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Aethlon Medical (AEMD)
|
1.8 | 1.3 | 0.0 | -6.9 | -- | -116.5 | -- | 0.3 |
| 62.7 | 8,162.7 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.0 | |
| 15.0 | 10,125.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.8 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.4 | |
| 58.5 | 8,913.0 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 177.5 | 10,637.8 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 15.3 | |
| 101.0 | 6,590.6 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.2 | 5.0 | |
| 89.6 | 5,350.1 | 1,579.2 | 145.6 | 14.3 | 8.9 | 36.9 | 3.2 | |
| 322.2 | 12,649.5 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.3 | 8.3 | |
| 167.6 | 9,458.6 | 785.1 | 41.5 | 9.9 | 2 | 232.8 | 4.6 |
Shareholding Pattern
View DetailsAbout Aethlon Medical (AEMD)
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology,... life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California. Read more
-
Chief Operating Officer
Mr. Guy F. Cipriani BS (Eng.), MBA
-
Chief Operating Officer
Mr. Guy F. Cipriani BS (Eng.), MBA
-
Headquarters
San Diego, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Aethlon Medical (AEMD)
What is the current share price of Aethlon Medical Inc (AEMD) Today?
The share price of Aethlon Medical Inc (AEMD) is $1.82 (NASDAQ) as of 04-Sep-2026 19:57 EDT. Aethlon Medical Inc (AEMD) has given a return of -88.24% in the last 3 years.
What is the current PB & PE ratio of Aethlon Medical Inc (AEMD)?
Since, TTM earnings of Aethlon Medical Inc (AEMD) is negative, P/E ratio is not available.
The P/B ratio of Aethlon Medical Inc (AEMD) is 0.25 times as on 04-Sep-2026, a 93 discount to its peers’ median range of 3.78 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
-0.39 |
0.57 |
2025 |
0.00 |
0.01 |
2024 |
0.00 |
0.01 |
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
What is the 52 Week High and Low of Aethlon Medical Inc (AEMD)?
The 52-week high and low of Aethlon Medical Inc (AEMD) are Rs 41.35 and Rs 1.67 as of 08-Sep-2026.
What is the market cap of Aethlon Medical Inc (AEMD)?
Aethlon Medical Inc (AEMD) has a market capitalisation of $ 1 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Aethlon Medical Inc (AEMD)?
Before investing in Aethlon Medical Inc (AEMD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.